Dr. Ronald Leuchter, MD – Los Angeles, CA
Improved chemosensitivity and survival in BRCA1 and BRCA2 heterozygotes with ovarian cancer.
Cass I., Varkey T., Baldwin R.L., Moslehi R., Narod S.A., Leuchter R.S., Lagasse L.D. and Karlan B.Y., Proc AACR 1069, 42:200Hormone receptor expression in uterine sarcomas: Prognostic and therapeutic roles.
Ioffe YJM, Li AJ, Walsh CS, Karlan BY, Leuchter RS, Forscher C, Cass I., Gynecol Oncol. 115(3):466-71, 12/2009Effect of obesity on survival in epithelial ovarian cancer.
Pavelka JC, Brown RS, Karlan BY, Cass I, Leuchter RS, Lagasse LD, Li AJ, Cancer 107:1520-1524, 2006